6-chloro-5-phenyl-2-picoline | 147936-60-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 6-chloro-5-phenyl-2-picoline
• 英文别名: 6-chloro-5-phenyl-2-methylpyridine；2-chloro-6-methyl-3-phenylpyridine；3-Phenyl-2-chloro-6-methylpyridine
• CAS: 147936-60-5
• 化学式: C₁₂H₁₀ClN
• 分子量: 203.671
• InChiKey: DGSPLSBEOOKTDQ-UHFFFAOYSA-N

物化性质

• 沸点：
  301.9±37.0 °C(Predicted)
• 密度：
  1.156±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5-甲氧基-4,4-二甲基-5-氧代戊酸 、 6-chloro-5-phenyl-2-picoline 生成 6-chloro-5-phenyl-2-picolyl chloride
  参考文献：
  名称：

  Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis

  摘要：

  具有公式I的化合物：##STR1## 是白三烯生物合成的抑制剂。这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。它们还可用于治疗心绞痛、脑血管痉挛、肾小球肾炎、肝炎、内毒素血症、牛皮癣、葡萄膜炎和移植排斥，并预防动脉粥样硬化斑块的形成。

  公开号：

  US05202321A1
• 作为产物：
  描述：

  2-甲基-5-苯基吡啶 在 双氧水 、 三乙胺 、 三氯氧磷 作用下， 以 二氯甲烷 、 溶剂黄146 为溶剂， 生成 6-chloro-5-phenyl-2-picoline
  参考文献：
  名称：

  Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816

  摘要：

  Thiopyrano[2,3,4-c,d]indoles are a new class of 5-lipoxygenase (5-LO) inhibitors. SAR studies have demonstrated that the thiopyran ring, the 5-phenylpyridine substituent, and an acidic functional group on a four-carbon C-2 side chain are all required for optimal inhibitor potency. In contrast, the indolic nitrogen may be substituted with a variety of lipophilic groups. As a result of the SAR investigation, 44 (L-691,816; 5-[3-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5-dihydro-1H-thiopyrano[2,3,4-c,d]indol-2-yl]-2,2-dimethylpropyl]-1H-tetrazole) has been identified as a potent inhibitor of the 5-LO reaction both in vitro and in a range of in vivo models. Compound 44 inhibits 5-HPETE production by both rat and human 5-LO and LTB4 synthesis in human PMN leukocytes (IC50s 16,75, and 10 nM, respectively). The mechanism of inhibition of 5-LO activity by compound 44 appears to involve the formation of a reversible deadend complex with the enzyme and does not involve reduction of the nonheme iron of 5-LO. Compound 44 is highly selective for 5-LO when compared to the inhibition of human FLAP, porcine 12-LO, and also ram seminal vesicle cyclooxygenase. In addition, 44 is orally active in a rat pleurisy model (inhibition of LTB4, ED50 = 1.9 mg/kg; 8 h pretreatment) as well as in the hyperreactive rat model of antigen-induced dyspnea (ED50 = 0.1 mg/kg;2-h pretreatment). Excellent functional activity was also observed in both the conscious allergic monkey and sheep models of asthma. In the latter case, the functional activity observed correlated with the inhibition of urinary LTE4 excretion.

  DOI：

  10.1021/jm00071a008

文献信息

• Aryl thiopyrano[2,3,4-C,D]indoles as inhibitors of leukotriene
  申请人：Merck Frosst Canada, Inc.

  公开号：US05314900A1

  公开（公告）日：1994-05-24

  Compounds having the formula I: ##STR1## are inhibitors of 5-lipoxygenase and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, psoriasis, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.

  具有I式化合物的化合物：##STR1##是5-脂氧合酶的抑制剂和白细胞三烯生物合成的抑制剂。这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。它们还有助于治疗心绞痛、脑血管痉挛、肾小球肾炎、肝炎、内毒素血症、银屑病、葡萄膜炎和异体移植排斥，并预防动脉粥样硬化斑块的形成。
• FUSED HETEROCYCLIC DERIVATIVES, THEIR PREPARATION METHODS THEREOF AND MEDICAL USES THEREOF
  申请人：Beijing Innocare Pharma Tech Co., Ltd.

  公开号：US20190185472A1

  公开（公告）日：2019-06-20

  The present invention relates to fused heterocyclic derivatives, processes for their preparation and their use in medicine. Specifically, the present invention relates to a novel derivative represented by the formula (I′), or its pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the derivative or its pharmaceutically acceptable salt thereof, and the method for preparing the derivative and its pharmaceutically acceptable salt thereof. The present invention also relates to the use of the derivative and its pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing the derivative and its pharmaceutically acceptable salt thereof in the preparation of medicines, in particularly as IDO inhibitor medicines, for treating and/or preventing cancers. Wherein each substituent of the formula (I′) is the same as defined in the specification.

  本发明涉及融合的杂环衍生物，其制备方法以及在医学上的应用。具体而言，本发明涉及一种由式(I′)表示的新型衍生物，或其药学上可接受的盐，含有该衍生物或其药学上可接受的盐的药物组合物，以及制备该衍生物及其药学上可接受的盐的方法。本发明还涉及利用该衍生物及其药学上可接受的盐，或含有该衍生物及其药学上可接受的盐的药物组合物，在制备药物中的应用，特别是作为IDO抑制剂药物，用于治疗和/或预防癌症。其中，式(I′)的每个取代基与规范中定义的相同。
• Rapid Room‐Temperature, Chemoselective C−C Coupling of Poly(pseudo)halogenated Arenes Enabled by Palladium(I) Catalysis in Air
  作者：Indrek Kalvet、Guillaume Magnin、Franziska Schoenebeck

  DOI：10.1002/anie.201609635

  日期：2017.2

  we herein report a general method based on PdI that allows for an a priori predictable chemoselective Csp2 -Csp2 coupling at C-Br in preference to C-OTf and C-Cl bonds, regardless of the electronic or steric bias of the substrate. The C-C bond formations are extremely rapid (<5 min at RT) and are catalyzed by an air- and moisture-stable PdI dimer under open-flask conditions.

  尽管Pd0催化的偶联反应中的化学选择性通常是不直观的，并且是配体/催化剂，底物和反应条件之间复杂相互作用的结果，但我们在此报告了一种基于PdI的通用方法，该方法可实现事先可预测的化学选择性Csp2- Csp2在C-Br处的偶联优先于C-OTf和C-Cl键，而与底物的电子或空间偏压无关。CC键的形成非常快（在RT下<5分钟），并在开瓶条件下被空气和水分稳定的PdI二聚体催化。
• Arylheteroaryl inhibitors of farnesyl-protein transferase
  申请人：Merck & Co., Inc.

  公开号：US05872136A1

  公开（公告）日：1999-02-16

  The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.

  本发明涉及抑制法尼基-蛋白转移酶（FTase）和致癌基因蛋白Ras的法尼酰化的化合物。该发明进一步涉及含有本发明化合物的化疗组合物以及抑制法尼基-蛋白转移酶和致癌基因蛋白Ras法尼酰化的方法。
• Thiopyrano (2,3,4-c,d) indoles as inhibitors of leukotriene biosynthesis
  申请人：MERCK FROSST CANADA INC.

  公开号：EP0518426A1

  公开（公告）日：1992-12-16

  Compounds having the formula I: are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, psoriasis, uveitis and allograft rejection and in preventing the formation of atherosclerotic plaques.

  具有式 I 的化合物： 是白三烯生物合成的抑制剂。这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。它们还可用于治疗心绞痛、脑痉挛、肾小球肾炎、肝炎、内毒素血症、银屑病、葡萄膜炎和异体移植排斥反应，以及预防动脉粥样硬化斑块的形成。